AtriCure Files Definitive Proxy Materials
Ticker: ATRC · Form: DEFA14A · Filed: Apr 6, 2026 · CIK: 0001323885
Sentiment: neutral
Topics: proxy-filing, shareholder-materials, medical-devices
TL;DR
AtriCure dropped proxy materials, get ready for shareholder votes.
AI Summary
AtriCure, Inc. filed a Definitive Additional Materials (DEFA14A) on April 6, 2026, related to proxy materials. The filing includes various documents such as a proxy notice and graphic files, likely for a shareholder meeting. The company is based in Mason, Ohio, and operates in the Surgical & Medical Instruments & Apparatus sector.
Why It Matters
This filing indicates AtriCure is proceeding with formal shareholder communications, which could precede significant corporate actions or decisions requiring shareholder approval.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently present new risks to the company or investors.
Key Players & Entities
- AtriCure, Inc. (company) — Filer of the DEFA14A
- 0001323885 (company) — CIK number for AtriCure, Inc.
- 2026-04-06 (date) — Filing date of the DEFA14A
- 7555 INNOVATION WAY MASON OH 45040 (location) — Mailing and Business Address for AtriCure, Inc.
FAQ
What type of filing is this DEFA14A for AtriCure, Inc.?
This is a Definitive Additional Materials filing, also referred to as Additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this filing submitted to the SEC?
The filing was submitted on April 6, 2026.
What is AtriCure, Inc.'s CIK number?
AtriCure, Inc.'s CIK number is 0001323885.
Where is AtriCure, Inc. located?
AtriCure, Inc.'s business and mailing address is 7555 INNOVATION WAY MASON OH 45040.
What industry does AtriCure, Inc. operate in?
AtriCure, Inc. operates in the Surgical & Medical Instruments & Apparatus sector.
Filing Stats: 129 words · 1 min read · ~1 pages · Grade level 15.8 · Accepted 2026-04-06 11:55:59
Filing Documents
- a2026atricureproxynotice-d.htm (DEFA14A) — 10KB
- a2026cardfrontforproxyfili.jpg (GRAPHIC) — 207KB
- a2026cardfrontforproxyfilia.jpg (GRAPHIC) — 233KB
- a2026noticebackforfiling.jpg (GRAPHIC) — 345KB
- a2026noticefrontforfiling.jpg (GRAPHIC) — 240KB
- 0001323885-26-000011.txt ( ) — 1422KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 14a-11(c) or Rule 14a-12 AtriCure, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.